<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02775266</url>
  </required_header>
  <id_info>
    <org_study_id>00159</org_study_id>
    <nct_id>NCT02775266</nct_id>
  </id_info>
  <brief_title>Effect of Antioxidant Intake on Resistin Levels In Patients With Gum Disease and Diabetes</brief_title>
  <acronym>EARGD</acronym>
  <official_title>Effect of Systemic Administration of ALA (Alpha Lipoic Acid) as an Adjunct to Scaling and Rootplaning on Serum Resistin Levels in Patients With Chronic Periodontitis and Type 2 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Panineeya Mahavidyalaya Institute of Dental Sciences &amp; Research Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Panineeya Mahavidyalaya Institute of Dental Sciences &amp; Research Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effectiveness of non surgical periodontal therapy in addition to
      antioxidant(ALA) on resistin levels in patients with type 2 diabetes and periodontal disease
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 40 patients with diabetes and chronic periodontitis attending the department of
      periodontics will be recruited in the study. 40 subjects will be randomly divided into two
      groups(control group and test group with 20 subjects in each group). Clinical parameters such
      as gingival index, periodontal index, random blood sugar levels(RBS) and glycosylated
      hemoglobin levels (Hb1aC) will be recorded at baseline and after 3 months and 2ml of blood
      sample will be collected by venepuncture ( baseline and after 3 months) and stored in
      Ethylenediaminetetraacetic acid containing vials to identify the levels of resistin in the
      patients by Enzyme linked immunosorbent assay. Group A will receive Alpha lipoic acid at
      baseline for a period of 3 months. Both the groups will receive scaling and rootplaning at
      baseline.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum Resistin Levels and HBAIC Levels</measure>
    <time_frame>3 months</time_frame>
    <description>2ml of blood sample will be collected by venepuncture at baseline and after 3 months and will be assessed by ELISA stored in EDTA containing vials to identify the levels of resistin in the patients by ELISA.
Glycosylated hemoglobin levels (Hb1aC) will be recorded at baseline and after 3 months and assessed by Spectrophotometer.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gingival Index</measure>
    <time_frame>3 months</time_frame>
    <description>Gingival index was recorded with william's periodontal probe at baseline and after 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing pocket depth</measure>
    <time_frame>3 months</time_frame>
    <description>Were recorded with william's periodontal probe at baseline and after 3 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical Attachment levels</measure>
    <time_frame>3 Months</time_frame>
    <description>Were recorded with william's periodontal probe at baseline and after 3 months</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Periodontitis</condition>
  <arm_group>
    <arm_group_label>ALA + Scaling and Root planing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Systemic antioxidant Alpha lipoic acid 1800mg/day in 3 divided doses for a period of 3 months(group B)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Scaling and root planing only</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive scaling and root planning at baseline and 3 months(group A)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Alpha lipoic acid</intervention_name>
    <description>Scaling and root planing will be done at baseline and systemic antioxidant Alpha lipoic acid 1800mg/day in 3 divided doses for a period of 3 months.</description>
    <arm_group_label>ALA + Scaling and Root planing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Scaling and Root planing</intervention_name>
    <description>Scaling and root planing will be done at baseline.</description>
    <arm_group_label>ALA + Scaling and Root planing</arm_group_label>
    <arm_group_label>Scaling and root planing only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Diabetic patients with Chronic periodontitis.

        Exclusion Criteria: Smokers, Pregnant &amp; lactating women, Prior periodontal therapy within 3
        months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kinnera Surapaneni, [MDS]</last_name>
    <role>Principal Investigator</role>
    <affiliation>PANINEEYA INSTITUTE OF DENTAL SCIENCES ROAD NO: 5, KAMALANAGAR DILSUKHNAGAR, HYDERABAD - 500060</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rekha R Koduganti, MDS Perio</last_name>
    <role>Study Director</role>
    <affiliation>Professor&amp;HOD Dept.of.Periodontics,PMVIDS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mohans Diabetic Centre</name>
      <address>
        <city>Hyderabad</city>
        <state>Telangana</state>
        <zip>500029</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <reference>
    <citation>Mealey BL, Oates TW; American Academy of Periodontology. Diabetes mellitus and periodontal diseases. J Periodontol. 2006 Aug;77(8):1289-303. Review.</citation>
    <PMID>16881798</PMID>
  </reference>
  <reference>
    <citation>Pendyala G, Thomas B, Kumari S. The challenge of antioxidants to free radicals in periodontitis. J Indian Soc Periodontol. 2008 Sep;12(3):79-83. doi: 10.4103/0972-124X.44100.</citation>
    <PMID>20142950</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2016</study_first_submitted>
  <study_first_submitted_qc>May 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 17, 2016</study_first_posted>
  <last_update_submitted>March 10, 2017</last_update_submitted>
  <last_update_submitted_qc>March 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Panineeya Mahavidyalaya Institute of Dental Sciences &amp; Research Centre</investigator_affiliation>
    <investigator_full_name>kinnera surapaneni</investigator_full_name>
    <investigator_title>PG student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Periodontitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antioxidants</mesh_term>
    <mesh_term>Thioctic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

